Treatment Resistant Schizophrenia Trs clinical trials

Explore recruiting treatment resistant schizophrenia trs clinical trials.

Recruiting treatment resistant schizophrenia trs studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Treatment Resistant Schizophrenia Trs trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, multi-center study, with a primary efficacy endpoint at 12 weeks, to determine the efficacy, safety, and tolerability of fixed doses of 15 mg bid and 30 mg bid of evenamide as add-on in patients with documented treatment-resistant schizophrenia, which is not adequately controlled by a stable therapeutic dose of the patient’s current antipsychotic medication(s).

Hungary, France, Bulgaria, Spain, Germany, Croatia +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Treatment Resistant Schizophrenia Trs trials by city

Treatment Resistant Schizophrenia Trs in Toronto Treatment Resistant Schizophrenia Trs in Vancouver Treatment Resistant Schizophrenia Trs in Montreal Treatment Resistant Schizophrenia Trs in Calgary Treatment Resistant Schizophrenia Trs in Edmonton Treatment Resistant Schizophrenia Trs in Ottawa Treatment Resistant Schizophrenia Trs in Winnipeg Treatment Resistant Schizophrenia Trs in Quebec City Treatment Resistant Schizophrenia Trs in Hamilton Treatment Resistant Schizophrenia Trs in Kitchener Treatment Resistant Schizophrenia Trs in London Treatment Resistant Schizophrenia Trs in Halifax Treatment Resistant Schizophrenia Trs in New York Treatment Resistant Schizophrenia Trs in Los Angeles Treatment Resistant Schizophrenia Trs in Chicago Treatment Resistant Schizophrenia Trs in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease